INTERCELL USA, INC.
Healthcare · Pharmaceutical Preparations · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Regulation FD disclosureAug 6, 2008
- Other material eventAug 1, 2008
- Other material eventJun 18, 2008
- Other material eventJun 3, 2008
- Director / officer changeMay 16, 2008
- Entered a material agreement · Director / officer changeMay 13, 2008
- Results of operationsMar 6, 2008
- New financial obligationJun 26, 2007
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13D/AINTERCELL USA, INC. - AMEND. NO. 4Feb 5, 2016
- CT ORDERNov 17, 2011
- CT ORDERMay 20, 2010
- 15-12GAug 14, 2008
- 4FORM 4 SUBMISSIONAug 7, 2008
- 4FORM 4 SUBMISSIONAug 7, 2008
- 4FORM 4 SUBMISSIONAug 7, 2008
- 4FORM 4 SUBMISSIONAug 7, 2008
- 4FORM 4 SUBMISSIONAug 7, 2008
- 4FORM 4 SUBMISSIONAug 7, 2008
- 4FORM 4 SUBMISSIONAug 7, 2008
- EFFECTAug 6, 2008
- EFFECTAug 6, 2008
- 4Aug 6, 2008
- 4Aug 6, 2008
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.